19.7 C
Munich
Wednesday, June 19, 2024

FDA to make decisions on several drug applications in July (NASDAQ:BIIB)

Must read

- Advertisement -


Headquarters of US Food and Drug Administration (FDA)

Grandbrothers

Several drugmakers are eagerly awaiting application decisions from the FDA in July.

The most significant decision comes on July 6, when Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) will find out if the agency will convert accelerated approval for

- Advertisement -
- Advertisement -



Source link

- Advertisement -

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article